Perimenopause and Your Biomarkers: What’s Changing and Why It Matters

Most women hear about perimenopause for the first time when something feels off — sleep falls apart at 42, anxiety shows up without an obvious cause, or periods start arriving on their own unpredictable schedule. They go to their doctor, get a single blood draw, and hear some version of “your labs look normal.”

The problem: perimenopause biomarkers fluctuate wildly, sometimes within the same week. A single blood test is a snapshot of a moving target. No single lab value diagnoses perimenopause, because the transition itself is defined by instability — hormones that used to cycle predictably are now swinging between high and low with no reliable pattern.

That doesn’t mean testing is useless. It means you need the right panel, drawn at the right time, interpreted by someone who understands what fluctuating values actually mean.

The Core Perimenopause Panel

At Protocol, our Hormonal Health protocol includes a specific biomarker panel for women between 35 and 55. This isn’t a generic hormone check. Each marker tells a different part of the story.

Estradiol

Estradiol is the primary estrogen your ovaries produce. In perimenopause, estradiol doesn’t just decline — it spikes and crashes. You can have a level of 400 pg/mL one week and 30 pg/mL the next. A single draw showing “normal” estradiol doesn’t rule anything out. What matters is the pattern over time and how your symptoms correlate with where estradiol lands on any given day.

FSH and LH

FSH (follicle-stimulating hormone) and LH (luteinizing hormone) are signals from your brain telling your ovaries to work harder. As ovarian function declines, FSH rises. But in early perimenopause, FSH can bounce between clearly elevated and completely normal within the same cycle. A single FSH of 8 doesn’t mean you’re not perimenopausal. A single FSH of 40 doesn’t mean you’re in menopause. The trend matters more than any individual number.

AMH (Anti-Mullerian Hormone)

AMH is the closest thing we have to a marker of ovarian reserve — how many eggs you have left. Unlike estradiol and FSH, AMH doesn’t fluctuate much with your cycle, which makes it more reliable as a single-draw test. For women 35 to 45, AMH provides useful context: a low AMH suggests the ovarian reserve is declining faster than average, even if periods are still regular. It won’t tell you when menopause will arrive, but it tells you where you are in the trajectory.

Progesterone

Progesterone rises after ovulation. If you’re still menstruating with some regularity, a progesterone draw on cycle day 19 to 22 confirms whether you actually ovulated that month. Many perimenopausal women have anovulatory cycles — they bleed, but no egg was released, which means progesterone stays flat. For women with irregular periods, a random progesterone draw still provides data, though it’s harder to interpret without a known cycle day.

SHBG (Sex Hormone-Binding Globulin)

SHBG is a protein that binds to sex hormones and determines how much is actually available to your tissues. High SHBG means less free estradiol and less free testosterone reaching your cells. SHBG rises with age, with oral estrogen, and with certain thyroid conditions. It’s one of the most overlooked markers in women’s hormone testing, and one of the most informative.

DHEA-S

DHEA-S (dehydroepiandrosterone sulfate) is an adrenal androgen that acts as a precursor to both estrogen and testosterone. It declines steadily with age. Low DHEA-S in perimenopause can contribute to fatigue, low libido, and loss of muscle mass. It’s a simple blood test that many providers skip entirely.

The Thyroid Connection

Perimenopause and thyroid dysfunction overlap so much in symptoms — fatigue, weight gain, brain fog, mood changes, hair loss — that they’re routinely confused. Our panel includes a full thyroid assessment: TSH, free T4, free T3, and TPO antibodies.

TPO antibodies matter because Hashimoto’s thyroiditis (autoimmune thyroid disease) is more common in women and often surfaces or worsens during perimenopause. A “normal” TSH with elevated TPO antibodies is a finding that changes management. Without checking antibodies, you miss the autoimmune component entirely.

Fasting Insulin

Fasting insulin is on the perimenopause panel because estrogen decline directly affects insulin sensitivity. As estrogen drops, cells become more resistant to insulin, so your body produces more of it to maintain normal blood sugar. Fasting glucose can look fine for years while fasting insulin is climbing — an early signal that metabolic health is shifting. This connects directly to our Metabolic Health protocol, where insulin resistance is tracked and addressed before it reaches a diabetes diagnosis.

Why a Single Blood Draw Misses the Picture

If you’ve been told your labs are “normal” but you feel clearly different, you’re not imagining it. Perimenopause is a state of hormonal instability, not a steady decline. Estradiol, FSH, and LH can all land in the reference range on the day of your draw and be wildly out of range three days later.

No single blood test can diagnose perimenopause. The diagnosis is clinical — based on your age, your symptoms, your cycle history, and labs interpreted in context. A provider who orders one FSH, sees it’s “normal,” and tells you everything is fine has missed the point.

At Protocol, we approach perimenopause testing differently:

• Repeated draws when initial results don’t match the clinical picture
• Cycle-timed labs when possible — progesterone on day 19 to 22, estradiol in the early follicular phase
• Correlation with symptoms rather than treating lab values as isolated data points
• Trending over time rather than making decisions on a single snapshot

When We Recommend DUTCH Testing

For some women, standard blood work isn’t enough. The DUTCH Complete (Dried Urine Test for Comprehensive Hormones) measures estrogen metabolites, progesterone metabolites, cortisol patterns, and androgen pathways from urine samples collected over a 24-hour period.

We recommend DUTCH testing for:

• Perimenopausal and postmenopausal women considering HRT — understanding estrogen metabolism pathways before starting therapy
• Premenopausal women with complex presentations — symptoms that don’t match blood work, or multiple overlapping hormonal complaints
• Women already on HRT — verifying how hormones are being metabolized, not just what blood levels show

DUTCH testing runs $300 to $400 and isn’t typically covered by insurance. It’s not needed for every woman, but when indicated, the detail it provides is worth the cost.

Perimenopause Affects Every System

Hormonal changes during perimenopause don’t stay in their lane. Falling estrogen triggers changes across cardiovascular health, bone density, metabolism, and sleep. Protocol treats perimenopause as a multi-system event, not an isolated hormonal issue.

Cardiovascular Risk Accelerates

Estrogen is cardioprotective. As it declines, LDL cholesterol rises, arterial stiffness increases, and cardiovascular risk climbs — sometimes sharply. Women who had excellent lipid panels at 40 can see meaningful changes by 50. Heart disease is the leading cause of death in women, and the menopausal transition is when risk starts building. Our Cardiovascular Health protocol tracks these markers alongside hormonal changes, because treating them in isolation misses the connection.

Bone Density Changes

Estrogen maintains bone density. The first five years after menopause are when bone loss is fastest — up to 20% of bone density can be lost in that window. If bone density isn’t measured before menopause, there’s no baseline to compare against. Our Body Composition protocol includes DEXA scanning for bone density assessment, timed to catch changes early rather than after a fracture.

Insulin Sensitivity Shifts

The estrogen-insulin connection means perimenopausal women often gain weight — specifically visceral fat — even without changing their diet or exercise. This isn’t a willpower problem. It’s a metabolic shift driven by hormonal changes. Tracking fasting insulin alongside estradiol makes the connection visible and actionable.

Sleep Disruption

Hot flashes and night sweats are the obvious sleep disruptors, but declining progesterone also affects sleep architecture directly. Progesterone has a calming effect on the brain — it acts on GABA receptors, the same system targeted by sleep medications. As progesterone drops, sleep quality often degrades even without obvious hot flashes. Our Sleep protocol addresses sleep disruption as both a symptom and a driver of other perimenopausal complaints.

What Falling Hormones Actually Do

The conversation around perimenopause often stays narrowly focused on hot flashes and irregular periods. The actual clinical picture is broader. Falling estrogen, progesterone, and testosterone collectively increase the risk of:

• Heart disease and stroke — estrogen loss removes a cardiovascular protector
• Weight gain, particularly visceral fat — insulin resistance shifts body composition
• Type 2 diabetes — the metabolic changes that begin in perimenopause can progress if unaddressed
• Osteoporosis — rapid bone loss in the years surrounding menopause

These aren’t distant risks. They begin during perimenopause, not after menopause. Testing for them early — and tracking changes over time — is the difference between reacting to a diagnosis and catching the shift while it’s still modifiable.

What To Do With This Information

If you’re between 35 and 55 and something has changed — your sleep, your energy, your cycles, your body composition, your mood — the right response isn’t to wait and see. It’s to measure.

Not a single FSH. Not a basic metabolic panel. A targeted assessment that captures the hormonal, metabolic, thyroid, and cardiovascular markers that actually change during this transition.

That’s what Protocol’s Hormonal Health protocol does. We test the right markers, at the right time, interpret them in the context of your symptoms and history, and track them over time so that decisions about treatment — whether that’s lifestyle optimization, HRT, or both — are based on data rather than guesswork.

If you’ve been told your labs are normal but you know something is different, you’re probably right. The labs were just the wrong ones, or drawn at the wrong time, or read without the right context.

Book a Discovery Call to discuss perimenopause testing and what a targeted biomarker assessment looks like for your situation.